Particle Sciences Renamed Lubrizol Life Science Health

Contract development and manufacturing organization (CDMO) Particle Sciences announced Tuesday that the company was recently renamed Lubrizol Life Science Health (LLS Health). 

The CDMO’s parent company, The Lubrizol Corporation, said the change is part of the incorporation of Particle Sciences into its new Lubrizol Life Science business group. Particle Science’s renaming comes after Lubrizol’s purchase of Bavaria Medizin Technologie GmbH, a CDMO based in Germany that produces intravascular and nonvascular devices. 

“We have built a strong reputation for complex drug product expertise with a flexible and proactive approach to solving drug development challenges,” Dr. Robert Lee, president of LLS Health’s CDMO division, said a company press release. “As LLS Health, this expertise and flexibility will continue, backed by the collective expertise of Lubrizol’s Life Science, and ongoing investments in our team and facilities.”

LLS Health recently opened a new 5000-sq-ft commercial-scale drug product manufacturing plant in Bethlehem, PA. One of the first products made by the company at the site was an aseptic fill for use in a sterile multi-use topical ophthalmic delivery device.  

“We are focused on expanding and strengthening our internal capabilities so we can continue to sustainably innovate the way we develop and manufacture drug products in partnership with customers, particularly those complex and differentiated products which require additional expertise and experience,” said Barbara Morgan, global business director, Pharmaceutical Solutions, LLS Health, in a statement. 

Lubrizol combined its Personal and Home and Health Care business lines into a new brand, Lubrizol Life Science, this July, Powder & Bulk Solidsreported, as part of the firm’s efforts to evolve with the beauty, health, and wellness markets.

For more news headlines, articles, and equipment reviews, visit our Equipment Zones

More Lubrizol articles:

Lubrizol's Particle Sciences Names New VP of Operations

Lubrizol Expands TPU Production Capabilities

Lubrizol Plans $25M Expansion of Kentucky Polymers Plant